Market Overview

UPDATE: Jefferies Raises PT on Centene on 2013 Guidance

Related CNC
Top 4 Mid-Cap Stocks In The Health Care Plans Industry With The Highest ROI
Centene's Georgia Subsidiary Announces Successful Reprocurement of Georgia Medicaid Contract

In a report published Wednesday, Jefferies reiterated its Hold rating on Centene Corp. (NYSE: CNC), and raised its price target from $41.00 to $43.00.

Jefferies noted, “2013 guidance continues to include optimistic assumptions that make it challenging to reach the high end of $2.60-2.90. Further, we may still be in for a cut. The market didn't care today (CNC up 6%) and the dominant focus seems to be on the LT growth opportunities, which are undeniably large. However, besides risk to 2013, 2014 EPS looks lofty and overlooks some risks.”

Centene Corp. closed on Tuesday at $44.99.

Latest Ratings for CNC

Jul 2015UBSUpgradesNeutralBuy
Jul 2015Goldman SachsDowngradesNeutralSell
Jul 2015JefferiesUpgradesHoldBuy

View More Analyst Ratings for CNC
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings


Related Articles (CNC)

View Comments and Join the Discussion!

Get Benzinga's Newsletters